We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sandoz Lawsuit Aims to Push FDA Decision on Omnitrope
Sandoz Lawsuit Aims to Push FDA Decision on Omnitrope
September 16, 2005
Generic heavyweight Sandoz has filed a lawsuit against the FDA accusing the agency of unlawfully delaying a decision on the firm’s application to market generic human growth hormone — a move that ramps up pressure on the FDA to issue guidelines for follow-on biologics.